SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001562762-23-000435
Filing Date
2023-12-01
Accepted
2023-12-01 10:30:29
Documents
12
Period of Report
2023-11-30
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K 20231130_8k.htm   iXBRL 8-K 22484
  Complete submission text file 0001562762-23-000435.txt   139804

Data Files

Seq Description Document Type Size
2 EX-101.SCH vaxx-20230922.xsd EX-101.SCH 1934
3 EX-101.LAB vaxx-20230922_lab.xml EX-101.LAB 15603
4 EX-101.PRE vaxx-20230922_pre.xml EX-101.PRE 11205
6 EXTRACTED XBRL INSTANCE DOCUMENT 20231130_8k_htm.xml XML 4170
Mailing Address 505 ODYSSEY WAY EXPLORATION PARK FL 32953
Business Address 505 ODYSSEY WAY EXPLORATION PARK FL 32953 (254) 244-5739
Vaxxinity, Inc. (Filer) CIK: 0001851657 (see all company filings)

IRS No.: 862083865 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41058 | Film No.: 231457924
SIC: 2834 Pharmaceutical Preparations